The virological consequences of low-level viraemia

Lancet Glob Health. 2022 Dec;10(12):e1699-e1700. doi: 10.1016/S2214-109X(22)00462-4.

Authors

Babayemi O Olakunde¹, Echezona E Ezeanolue²

Affiliations

¹ Department of Community Prevention and Care Services, National Agency for the Control of AIDS, Abuja, Nigeria; Center for Translation and Implementation Research, University of Nigeria, Nsukka, Enugu, Nigeria.
² Center for Translation and Implementation Research, University of Nigeria, Nsukka, Enugu, Nigeria; HealthySunrise Foundation, Las Vegas, NV, USA. Electronic address: eezeanolue@gmail.com.

PMID: 36400076
DOI: 10.1016/S2214-109X(22)00462-4

No abstract available

Publication types

Comment

MeSH terms

Antiretroviral Therapy, Highly Active*
CD4 Lymphocyte Count
Humans
Viremia* / drug therapy